Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

  • Cardoso, Fatima M.D.
  • Parke, Susanne M.D.
  • Brennan, Donal J. M.B., Ph.D.
  • Briggs, Paula M.B., Ch.B.
  • Donders, Gilbert M.D.
  • Panay, Nick F.R.C.O.G.
  • Haseli-Mashhadi, Nazanin M.Sc.
  • Block, Michael Ph.D.
  • Caetano, Cecilia M.D.
  • Francuski, Maja Ph.D.
  • Haberland, Claudia Ph.D.
  • Laapas, Kaisa M.Sc.
  • Seitz, Christian M.D.
  • Zuurman, Lineke M.D.

  • 1Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

    2ABC Global Alliance, Lisbon, Portugal

    3Bayer, Berlin

    4University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin

    5Liverpool Women’s Hospital, Liverpool, United Kingdom

    6Department of Clinical Research for Women, Femicare, Tienen, Belgium

    7Department of Obstetrics and Gynecology, University Hospital, University of Antwerp, Antwerp, Belgium

    8Queen Charlotte’s and Chelsea Hospital, Imperial College London, London

    9Bayer, Reading, United Kingdom

    10Bayer, Leverkusen, Germany

    11Bayer, Basel, Switzerland

    12Bayer, Espoo, Finland

    13Charité–Universitätsmedizin Berlin, Berlin

Dr. Cardoso can be contacted at [email protected].

New England Journal of Medicine Publish Ahead of Print, June 02, 2025. | DOI: 10.1056/NEJMoa2415566
Copyright © 2025 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF